It is about interpretation of information delivered as results of pleural fluid exams, including physical characteristics, differentiation between transudates and exudates, cell counts, culture and cytology.
It is about interpretation of information delivered as results of pleural fluid exams, including physical characteristics, differentiation between transudates and exudates, cell counts, culture and cytology.
csf is the fluid which is present around the brain and spinal card as a shock absorber, provide nutrition and keep them wet. CSF analysis is an important tool in the diagnosis of many disease especially in meningitis and hemorrhages and for the diagnosis of many malignancy.
define hematocrit and how's the test is performed
if hematocrit is abnormal what are the symptoms
risks of getting rbc count
if rbc is abnormal what are the consequences
prepare for blood collection for hematocrit
Urine analysis is an integral part of a clinical laboratory. automation techniques in urine biochemistry, their priniciplas and microscopy along with their advantages and disadvantages are outlined.
A basic and worth information for diagnostic is urine microscopy. ideally it should be by the physician at his clinic to add and correlate diagnosis promptly. this will make physician confident in dealing with patients. it also help in follow up the consequences in some important glomerulopathies.
csf is the fluid which is present around the brain and spinal card as a shock absorber, provide nutrition and keep them wet. CSF analysis is an important tool in the diagnosis of many disease especially in meningitis and hemorrhages and for the diagnosis of many malignancy.
define hematocrit and how's the test is performed
if hematocrit is abnormal what are the symptoms
risks of getting rbc count
if rbc is abnormal what are the consequences
prepare for blood collection for hematocrit
Urine analysis is an integral part of a clinical laboratory. automation techniques in urine biochemistry, their priniciplas and microscopy along with their advantages and disadvantages are outlined.
A basic and worth information for diagnostic is urine microscopy. ideally it should be by the physician at his clinic to add and correlate diagnosis promptly. this will make physician confident in dealing with patients. it also help in follow up the consequences in some important glomerulopathies.
Our body is made up of millions of cells, which group together to form different organs. Some cells function in their individual form and move throughout the body via blood. Complete Blood Count (CBC) is all about these cells present in the blood, which can help determine health problems.
Lab Tests are tools that provide information about the client.
Tests may be used for basic screening as part of a wellness check.
Frequently tests are used to help confirm a diagnosis, monitor an illness, and provide valuable information about the client’s response to treatment.
Interpretation and Clinical Significance of some Clinical Laboratory Tests - ...Bigin Gyawali
Certainly, clinical laboratory tests play a crucial role in assessing the function and health of various organ systems in the body. Let's discuss the clinical significance of some common laboratory tests for each of the mentioned systems:
1. **Cardiovascular System:**
- **Complete Blood Count (CBC):** Evaluating red blood cell count, hemoglobin, and hematocrit levels can help identify anemia, which may contribute to cardiovascular issues.
- **Lipid Profile:** Measures cholesterol levels (LDL, HDL, and total cholesterol), triglycerides, and can help assess the risk of atherosclerosis and cardiovascular disease.
2. **Endocrine System:**
- **Thyroid Function Tests (TFTs):** TSH, T3, and T4 levels are assessed to diagnose thyroid disorders. An imbalance in thyroid hormones can affect metabolism and cardiovascular function.
- **Hemoglobin A1c (HbA1c):** Monitors long-term glucose control and is essential in managing diabetes, a condition that can impact multiple organ systems, including the cardiovascular and renal systems.
3. **Gastrointestinal System:**
- **Liver Function Tests (LFTs):** Assess the health of the liver by measuring enzymes (ALT, AST, ALP), bilirubin, and proteins. Abnormalities may indicate liver disease or dysfunction.
- **Stool Tests (e.g., fecal occult blood):** Detects blood in the stool, which may indicate gastrointestinal bleeding or conditions such as colorectal cancer.
4. **Hematologic System:**
- **Coagulation Panel (PT, aPTT, INR):** Evaluates the blood's clotting ability. Abnormalities may suggest bleeding disorders or an increased risk of thrombosis.
- **Complete Blood Count (CBC):** Assesses the cellular components of blood, including red and white blood cells and platelets, helping to diagnose anemias, infections, and blood disorders.
5. **Renal System:**
- **Blood Urea Nitrogen (BUN) and Creatinine:** Evaluate kidney function. Elevated levels may indicate impaired renal function, suggesting acute or chronic kidney disease.
- **Urinalysis:** Examines urine for abnormalities such as protein, blood, or glucose, providing insights into kidney and urinary tract health.
6. **Respiratory System:**
- **Arterial Blood Gas (ABG) Analysis:** Assesses oxygen and carbon dioxide levels in the blood, helping diagnose respiratory and metabolic disorders.
- **Pulmonary Function Tests (PFTs):** Measures lung function, aiding in the diagnosis and monitoring of conditions such as asthma or chronic obstructive pulmonary disease (COPD).
Interpretation of these tests requires a comprehensive understanding of the patient's medical history and clinical presentation. Abnormal results can guide further diagnostic investigations and help healthcare professionals develop appropriate treatment plans. Regular monitoring of these parameters is vital for managing chronic conditions and preventing complications.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
3. WHAT IS COMPLETE
BLOOD COUNT?
A complete blood count (CBC) is a test that
counts the cells that make up your blood: red
blood cells, white blood cells, and platelets. Your
doctor may order a CBC as part of a routine
checkup or to:
4. • Check for anemia, a condition that causes you to
have fewer red blood cells than usual
• Find out if you have another health issue or to explain
symptoms like weakness, fever, bruising, or feeling
tired
• Keep an eye on a blood condition
• See how medications, medical conditions, or treatments
like chemotherapy are affecting your blood
5. HOW IS A CBC DONE?
If the CBC is the only blood test you are having, you
can eat and drink like you usually would. Your part of
the test is simple and takes just a few minutes. A nurse
or lab tech will take a sample of blood by putting a
needle into a vein in your arm. Afterward, you can leave
and get back to your routine. They will send the blood
to a lab for review.
6. WHAT DOES A
CBC MEASURE?
The test can tell your doctor a lot about your overall health. It
measures:
•White blood cells (WBCs). These help your body fight germs. If you
have too many of them, it could be a sign of inflammation, infection, a
medical reaction, or another health condition. If it’s low, you could be at a
higher risk for infection. A medication, a viral infection, or a bone marrow
disease could also cause a low count.
7. •Red blood cells (RBC). These deliver oxygen throughout your
body. They also help carry carbon dioxide. If your RBC count is too
low, you may have anemia or another condition.
•Hemoglobin (Hb or Hgb). This is the protein in your blood that
holds oxygen
•Hematocrit (Hct). This test tells how much of your blood is made up
of red blood cells. A low score may be a sign that you don’t have
enough iron, the mineral that helps your body make red blood cells. A
high score could mean you’re dehydrated or have another condition.
8. •Mean corpuscular volume (MCV). This is the average
size of your red blood cells. If they’re bigger than usual,
your MCV will be higher. That could happen if you have
low vitamin B12 or folate levels. If your red blood cells
are smaller, you could have a type of anemia.
•Platelets. These help your blood clot.
9. CBC RESULTS
When you get your report, you’ll see two columns:
a “reference range” and your results. If your results are inside
the reference range, they’re considered normal. If your results
are higher or lower than the reference range, they’re abnormal.
Mild anemia is one of the most common reasons your results
might be off.
10. Each lab has different ways of studying
your blood. So the reference range will depend
on the lab that handles your blood tests. It’s also
based on things that can affect your blood like
your age, your sex, and how high above sea level
you live.
In general, the reference ranges are:
11. •White blood cells: 4500 to 11,000 cells per microliter
(cells/mcL)
•Red blood cells: 4.5 million to 5.9 million cells/mcL for
men; 4.1 million to 5.1 million cells/mcL for women
•Hemoglobin: 14 to 17.5 grams per deciliter (gm/dL)
for men; 12.3 to 15.3 gm/dL for women
•Hematocrit: 41.5% to 50.4% for men; 35.9% to 44.6%
for women
•Mean corpuscular volume: 80 to 96
•Platelets: 150,000 to 450,000 platelets/mcL
12. WHAT ELSE MIGHT MY CBC
TELL ME?
Your doctor might order more results to learn whether
you have an illness or blood condition, including:
• Mean corpuscular hemoglobin (MCH). This test
tells how much hemoglobin is in your typical red blood
cell.
• Mean corpuscular hemoglobin concentration
(MCHC). This measures the concentration of
hemoglobin in a certain amount of blood.
• Red cell distribution width (RDW). This shows
how your much your red blood cells vary in size.
13. • Reticulocyte count. This test measures the
number of new red blood cells in your body.
• Mean platelet volume (MPV). This result gives
the average size of the platelets in your blood.
• Platelet distribution width (PDW). This shows
how much your platelets vary in size.
• White blood cell differential. There are five
types of white blood cells: basophils, eosinophils,
lymphocytes, monocytes, and neutrophils. This test
shows how many of each kind you have.
14. WHY DO HEALTHCARE
PROVIDERS ORDER CBCS?
CBCs are an important part of a yearly physical exam. Providers also order
CBCs to monitor the side effects of some prescription medications.
Your provider may order a CBC to:
• Detect abnormalities in your blood that may be signs of disease.
• Diagnose or monitor many different disorders, conditions and
infections.
• Evaluate your overall health.
• Rule out conditions, disorders and disease.
• Monitor various blood diseases.
15. -Healthcare providers use complete blood
counts to manage disease and help you stay
healthy. With one sample of blood, CBCs can
help screen for hundreds of disorders,
conditions and infections. A CBC can detect
conditions early, sometimes before you have
symptoms, so treatment can start as soon as
possible. CBCs are an essential tool in
maintaining good overall health.
16. WHEN IS A CBC
PERFORMED?
You may need a CBC if you have symptoms such as:
• Bruising or bleeding.
• Fatigue, dizziness or weakness.
• Fever, nausea and vomiting.
• Inflammation (swelling and irritation) anywhere in the body.
• Joint pain.
• Problems with heart rate or blood pressure
17. WHAT ARE THE RISKS OF
THIS TEST?
A CBC is a safe, common test. There are
no risks involved, and your provider only
removes a small amount of blood. Rarely,
some people feel a little faint or lightheaded
after a CBC.
18. WHAT DOES A CBC
DETECT?
A CBC blood test can help your provider diagnose a wide
range of conditions, disorders, diseases and infections,
including:
•Anemia (when there aren’t enough red blood cells to carry
oxygen through the body).
•Bone marrow disorders, such as myelodysplastic syndromes
19. •Disorders such as agranulocytosis and thalassemias and sickle
cell anemia.
•Infections or other problems that cause abnormally low white
blood cell count or high white
blood cell count.
•Several types of cancer, including leukemia and lymphoma.
•Side effects of chemotherapy and some prescription
medications.
•Vitamin and mineral deficiencies
20. NURSING
CONSIDERATIONS
1. Explain test procedure. Explain that slight discomfort may be felt
when the skin is punctured.
2. Encourage to avoid stress if possible because altered physiologic
status influences and changes normal hematologic values.
3. Explain that fasting is not necessary. However, fatty meals may
alter some test results as a result of lipidemia.
21. 4. Apply manual pressure and dressings over
puncture site on removal of dinner.
5. Monitor the puncture site for oozing or
hematoma formation.
6. Instruct to resume normal activities and diet.
22. WHAT ARE THE BENEFITS
OF THIS TEST?
A CBC gives your provider a picture of your
overall health. Using a small amount of blood, a
CBC can help detect hundreds of conditions,
disorders and infections. It allows your provider to
monitor your health, screen for disease and plan and
adjust treatment.
23. WHEN SHOULD I KNOW
THE RESULT OF THE TEST?
Results are usually ready within a few days.
Sometimes it only takes 24 hours to get results. Your
provider will contact you to explain the results and
discuss next steps. If your blood cell counts are outside
of the normal range, your provider may order follow-up
tests.
24. WHAT SHOULD I EXPECT
AFTER THE TEST?
You’ll have some gauze and a bandage on your
arm, secured with tape. Your arm may be a little
sore for a few hours. You may develop a small
bruise where your provider inserted the needle.
25. WHEN SHOULD I CALL MY
DOCTOR OR NURSE?
your provider will review the results
of your CBC with you. If you have
questions about the results, call your
provider.